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ABSTRACT
As modern medicine becomes increasingly personalized, psychiatry lags behind, using poorly-under-
stood drugs and therapies to treat mental disorders. With the advent of methods that capture large quan-
tities of data, such as genome-wide analyses or fMRI, machine learning (ML) approaches have be-
come prominent in neuroscience. This is promising for studying the brain’s function, but perhaps more 
importantly, these techniques can potentially predict the onset of disorder and treatment response.
Experimental approaches that use naive machine learning algorithms have dominated research in compu-
tational psychiatry over the past decade. In a critical review and analysis, I argue that biologically realis-
tic approaches will be more effective in clinical practice, and research trends should reflect this. Hybrid 
models are considered, and a brief case study on major depressive disorder is presented. Finally, I propose 
a novel four-step approach for the future implementation of computational methods in psychiatric clinics.
Examining the Viability of Computational Psychiatry: 
Approaches into the Future
By Mitchell Ostrow1
1Program in Neuroscience, Yale University; Department of Statistics and Data 
Science, Yale University
INTRODUCTION
Psychiatrists traditionally utilize behavior and psychology in the 
clinic but have long sought to ground the practice in biology. Un-
fortunately, contemporary research has yet to translate, due to the 
inevitable truth that the brain cannot be carved at its joints. This 
means that enormous neural complexity has prevented modern 
methods from sufficiently elucidating pathophysiological process-
es. Similarly, the conceptual bridges between cellular biology, sys-
tems neuroscience, and behavior are shaky given the limits of neu-
roscientific theory as well as data collection capabilities. 
There exist only a handful of mechanistic theories of dysfunction 
in mental illness, such as the dopamine or glutamate hypothesis in 
schizophrenia (Seeman, 1987; Gordon, 2010). These first steps have 
refuted the contemporary understanding disorders as having one-
to-one biological mappings. The practical conception of disorder is 
defined in the Diagnostic and Statistical Manual of Mental Disor-
ders (5th ed.; DSM-V; American Psychiatric Association, 2013) on 
the basis of symptom presentation. This is likely incorrect for a few 
reasons. First, a DSM-V disorder might encapsulate subtypes with 
varying etiologies. Second, the prevalence of comorbidities such 
as depression and anxiety (according to Brady et al., 1992, almost 
62%) likely indicates overlapping or interacting neural correlates 
of various pathologies. Pervasive comorbidity and heterogeneity in 
psychologically-defined disorders have provoked the Research Do-
main Criteria (RDoC) approach, which seeks to rebuild psychiatric 
disorders from biology upwards (Insel et al., 2010).
Neuroscience faces an accelerating deluge of information which 
analytic trends have not reflected. Imaging studies often fail to 
replicate (Jahanshad, 2019). A common concern has been limited 
sample size; open-source initiatives seek to mitigate this issue by 
sharing data (Poldrack & Gorgolewski, 2019). Data preprocessing 
techniques in fMRI vary between sites, which have significant in-
fluence on results (Smith & Nichols, 2018). Additionally, statistical 
techniques used in much of neuroscience are simply out of date. 
Linear models are interpretable, but neural systems are highly non-
linear and analyses should reflect this (Friston, 2004).
In this paper, I analyze the effectiveness of computational tools for 
clinical psychiatry research and practice. Although the clinical im-
plementation of these methods is the ultimate goal, I seek to exam-
ine the viability of computational psychiatry as a research method 
for developing precision psychiatry. This is not to say that we can-
not examine how they might fit into the clinic itself. The beauty of 
these tools is that they can often be used predictively and to gener-
ate understanding, allowing for usage in both research and practice. 
However, the field is a long way from success in either domain. 
Thus, I seek to provide a comprehensive review of computational 
methods applied to psychiatry in general in the hopes of providing 
a clearer picture about where the field is headed. 
BRIEFLY: WHAT IS COMPUTATIONAL PSYCHIATRY?
Computational psychiatry as a discipline is divided into theory- 
and data-driven approaches (Huys et al., 2016). Theory-driven ap-
proaches model the biological processes that generate dysfunction, 
whereas data-driven models remain agnostic to underlying causes, 
utilizing statistical trends in data to make inferences on new sam-
ples (Bennet et al., 2019). Montague et al. (2012) define a frame-
work for five subdomains: a) data-mining, modeling and pheno-
typing, b) producing new biological hypotheses, c) large-scale data 
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sharing, d) biomarker discovery, and e) application to therapeutics. 
Data-driven models often utilize supervised ML methods, which 
have the goal of predicting labels from labelled data (Shatte et al., 
2019). Another type, unsupervised learning, extracts statistical pat-
terns from data. Principal component analysis, a linear technique 
that reduces the dimensions of data into sub-components, is popu-
lar due to its interpretability (Drysdale et al., 2017; Bondar et al., 
2020). In theoretical work, researchers seek to infer cognitive or 
neurological states from behavior or neuroimaging. Models, such 
as dynamic causal models (see Theoretical Approaches) seek to 
represent disorder of biophysical processes and are often utilized in 
conjunction with neuroimaging (Friston et al., 2017). 
The bridge across the chasm between computational psychiatry re-
search and the clinic is neither stable nor complete. In this analogy, 
theory-driven approaches might be the slow yet precise construc-
tion of an overpass, whereas data-driven approaches are a ramp to 
facilitate a motorcycle jump, Evil Knievel-style. The latter method 
is faster, but risk and uncertainty are significantly higher as they 
do not refer to any underlying disorder. Additionally, data-driven 
approaches are plagued with poor methodology (Rutledge et al., 
2019).
Computational approaches can be quite relevant to some psychiatry 
work (Chekroud et al., 2017), for example in predicting the risk of 
a patient experiencing their first psychotic episode (Koutsouleris et 
al., 2016; Adams et al., 2016) or categorizing prognosis (Kessler 
et al., 2016). Other types of predictions include finding best possi-
ble treatment for a set of symptoms (Paulus & Thompson, 2019), 
forecasting treatment response (Webb et al., 2018), or making di-
agnoses (Kalmady et al., 2019; Hahn et al., 2020). Unsupervised 
approaches can find new endophenotypes of a disorder that might 
cause variation in therapeutic responses (Drysdale et al., 2017; 
Chand et al., 2020). 
In the face of overwhelming data, choosing the correct approach 
is crucial. To develop clinically effective systems, all relevant data 
should be considered, including electronic health records, -omics, 
imaging, internet activity, and more. The abundance of data can in-
troduce corrupting noise, which necessitates statistical techniques 
to enhance signal. Furthermore, contemporary databases tend to 
skew towards specific populations, such as white men or UK citi-
zens, which must be corrected (Monteith et al., 2015). Finally, data 
privacy is of utmost concern.
WHY HAS COMPUTATIONAL PSYCHIATRY NOT YET 
TRANSLATED TO CLINICAL PRACTICE?
In other medicines, computational approaches are flourishing, for 
example in classifying the presence of cancer (Yoo et al., 2019). 
Deep learning (see Theoretical Approaches for a brief explanation) 
to classify diabetic retinopathy has entered clinical trials (Rajal-
akshmi, 2020). However, psychiatric data are often not as straight-
forward, given their neurological complexity, subjective nature of 
experience, and clinical heterogeneity.
While numerous studies have demonstrated the impressive capa-
bility of these systems, they maintain insufficient generalizability, 
such that clinicians have not adopted or even tested them in ran-
domized clinical trials (Woo et al., 2017). While clinical psychia-
try itself is imperfect, occasionally prescribing drugs through trial 
and error, which risks long-term side effects, replacing this with a 
similarly erroneous system is illogical and expensive (Chekroud 
& Koutsouleris, 2017). Until computational psychiatry can create 
useful solutions, it will remain out of the clinic. 
It should be noted that the methods themselves are novel. Neuro-
imaging is both time consuming and expensive (Vu et al., 2018, 
Chandler et al., 2019). The shift in perspective of fMRI studies 
from functional region to whole-brain approaches (Richiardi, 2013) 
emphasizes that a stronger understanding of neural computation is 
necessary for selecting both methods and relevant data in research. 
Neuroimaging has proved especially difficult in the search for bio-
markers—Dwyer et al. (2018) notes that fMRI studies utilizing 
classical statistics have a 70% false positive rate, meaning that ex-
periments will find a statistically significant correlation in the data 
more often than not, even if none is truly there. Similarly, current 
treatment-predictive models do not incorporate the ability to select 
multiple therapies, a regular practice in the clinic. 
Woo et al. (2016) emphasizes that most computational methods for 
psychiatry remain in the research stages of development. Yet da-
ta-driven approaches have often outmatched clinical counterparts 
in various clinically-relevant tasks (Bzdok & Meyer-Lindenberg, 
2018). So why are these results insufficient to be instantiated in 
hospitals? It should be noted that most disorders lie in some ab-
stract symptom space where different medical parameters define 
the dimensions, and an expert-defined decision boundary, which 
classifies data points based on their location relative to the bound-
ary, determines diagnosis. Samples near the boundary will be dif-
ficult to classify, especially if we do not understand the nature of 
the disease. In these cases, which are frequent, naive approaches 
might not work as desired, leading to poor generalization among 
patient types (Schultze-Lutter et al., 2018). Yet some models have 
found relative success, such as Chekroud et al. (2017) which found 
three generalizable symptom clusters in the Sequenced Treatment 
Alternatives to Relieve Depression (STAR*D) dataset (MDD, n = 
4039) that characterized antidepressant responsiveness.
FAILURE TO REPLICATE
Neuroimaging studies tend to overfit, or fail to generalize beyond, 
the experimental data. These studies suffer from the curse of di-
mensionality due to the small sample size. As described by Huys 
et al. (2016), when the number of features exceeds the number of 
samples, it is possible to perfectly distinguish n patients from m 
controls by using n+m-1 features. Functional connectivity matri-
ces, which measure in fMRI how the changes in activity of one 
brain region correlates with the changes in another, often have close 
to 100,000 features per data point, while sample sizes are minimal, 
with close to 100 subjects (Venkatesh et al., 2020). Utilizing a re-
gion of interest approach, which focuses on a particular location 
of the brain, reduces dimensions drastically. Increasing the size of 
datasets or selecting meaningful features via regularization tech-
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niques or theory could further mitigate these issues (Huys et al., 
2016). 
As mentioned previously, psychiatric data is noisy. Approaches that 
focus on diagnosis directly from data, such as Zhu et al. (2018), 
suffer from high rates of misclassifications (Chekroud, 2017) and 
do not exceed clinical accuracies as they still utilize the DSM-V 
criteria. Biomarkers might be shared across disorders when these 
definitions are used, further confounding separability (Fernandes 
& Berk, 2017). 
Commonly used algorithms cannot represent the complex relation-
ships required in psychiatry. Powerful methods such as deep learn-
ing have been examined but only as proof-of-concept (Durstewitz 
et al., 2019; He et al., 2020). Additionally, common optimization 
techniques such as feature selection, which selects variables based 
on how much they improve a model, can have detrimental effects 
when attempting to generalize to new populations (Paulus et al., 
2019). 
However, the key problem behind data-driven failures is that their 
methods do not take into account the temporality and plasticity 
of mental illness. These models capture a snapshot of the clinical 
picture, abstracting away the dynamics of neurological function. 
Thus, despite trends towards best practices, they will likely fail to 
ultimately reach the acceptable threshold of generalizability for 
clinical usage alone. 
CURRENT TRENDS
The two obvious solutions to the major problems (limited data and 
lack of generalizability) are currently being addressed by open-
source projects, triggering an upward trend in sample size. The 
community has responded via initiatives such as the Human Brain 
Project and the Human Connectome Project, which have collected 
large databases of fMRI recordings from thousands of people (Vu 
et al., 2018). These projects are an excellent step in the right direc-
tion, and have yielded significant findings in basic neuroscience 
research. However, scientists seeking to use the data for clinical re-
search continue to be wary of these sample sizes, as well as the fact 
that the data regularly comes from one source, which can increase 
bias (Smith & Nichols 2018). He et al. (2020) found that increasing 
the sample size on a behavioral and demographic classification task 
from 100 subjects to 8000 improved the correlation of predicted 
and ground truth labels from <0.05 to 0.25, a promising increase. 
Similarly, Hahn et al. (2020) utilized data from 27 recording sites 
provided by the ENIGMA Addiction working group, which limits 
single-site bias. 
Yet these are often not enough. Drysdale et al. (2017) found two 
clusters of depression with different symptom profiles based on 
resting state fMRI that offered separable clinical symptom profiles 
and differential treatment responses to Transcranial Magnetic Stim-
ulation on 1,188 training samples over multiple sites. Despite these 
precautions, the study failed to replicate (Chekroud 2020, personal 
correspondence). If computational methods cannot satisfy the ro-
bustness criteria of research, how can we hope to integrate them in 
practice?
As studies move into clinical testing, they will need even more rig-
orous standards of validation. Algorithms will need to display reli-
ability (performing adequately for long periods of time), scalability 
(increasing production and distribution to customers), and ease of 
implementation (allowing non-experts to utilize the technology) 
(Nair et al., 2020) via clinical trials. Paulus et al. (2016) detail a 
prospective pipeline, with phases requiring robustness, clinical va-
lidity, efficacy in a randomized clinical trial, clinical effectiveness, 
and post-marketing refinement. Five years later, no method has 
passed phase one. What further changes could facilitate progress?
To develop a robust predictive or explanatory model of mental 
health disorders, data should be used in the same way as psychia-
trists. Clinicians take the past into account via patient histories, and 
so too should computational systems (Stiefel et al., 2019). Second, 
increased emphasis should be placed on theory-based research, 
as models derived from theory are more likely to generalize and 
potentially lead to clinically-relevant findings (Huys et al., 2016). 
While machine learning is effective at tasks such as image recogni-
tion (Kirzhevsky et al., 2012), these are not as complex as psychia-
try or neuroscience. An informed approach is paramount. 
This is not to say that the data-driven research should be abandoned 
entirely. Rather, it will have a position in clinical practice, perhaps 
as a first pass system (see my four-step proposal), while the more 
neuroscientifically-grounded models will further the analysis. Woo 
et al. (2017) note that the majority (75%) of neuroimaging stud-
ies that search for biomarkers for disorder apply a data-driven ap-
proach, underscoring the community’s excitement towards ML, but 
excitement is not enough. Similarly, the weak explanatory power of 
genomics or neuroimaging is not enough to directly prove informa-
tive or clinically efficacious (Chekroud, 2018). 
THEORETICAL APPROACHES
Theory-driven models draw upon decades of neuroscience (Flagel 
et al., 2019). They include biophysical simulations and behavioral 
models in varying degrees of precision. They can account for het-
erogeneity in standard pathophysiology by adjusting various pieces 
of a generalized framework to better fit individual subjects (Murray 
et al., 2018). In the following subsections, I briefly detail a few 
examples of theoretical models.
Generative Models
Generative models make inferences about unobservable neural 
states by sequentially taking in data, usually from neuroimaging, 
and updating the inner state of the model to better match the data. 
Neuroimaging models are based on properties of functional con-
nectivity networks, which generalize small-scale neural features 
to systems-level responses (Stephan et al., 2015). fMRI, the pre-
dominant form of neuroimaging for these models, measures the 
Blood-Oxygen Level Dependent (BOLD) response. This is a cor-
relate of neural activity, recorded at a millimeter scale, that abstracts 
layers of microcircuit interactions and single-neuron physiology. 
The most popular form of generative models, called dynamic caus-
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al models, utilize a system of mathematic differential equations to 
represent high-level features in fMRI (Stephan et al., 2015). These 
can be used in psychiatry to examine how different dysfunctions 
in the neural state can lead to the observations from experimen-
tal recordings. In the future, psychiatrists could fit these models to 
patients to gain a deeper understanding of their specific biological 
dysfunction.
Reinforcement Learning
Reinforcement learning (RL) models have seen newfound success 
in representing psychiatric dysfunction. RL is a machine-learning 
approach that seeks to build adaptive algorithms that can maximize 
reward in a so-called environment. These are not explicitly taught 
the solution, as in supervised learning, but rather have to figure it 
out themselves. Neuroscientific RL is paralleled by artificial intel-
ligence research, and contributions in one domain benefit the oth-
er. Computational algorithms such as the successor representation, 
an efficient form of reinforcement learning that has empirical ties 
to the function of the striatum in the brain (Dayan, 1993; Gersh-
man, 2018), draw from both neuroscience and artificial intelligence 
(AI). Huys et al. (2015) used this algorithm to argue that depressive 
symptoms might draw from dysfunction in state-action evaluation, 
which is a particular step in the RL framework that requires an agent 
to choose a particular action given the state of the environment. 
Through decision theory, an interdisciplinary field that seeks to 
study how decisions are made from an algorithmic and statistical 
perspective, psychiatric disorders can be viewed as occurring via 
self-reinforcing behavioral dysfunction: solving the wrong prob-
lem, such as in substance addiction, solving the right problem in 
the wrong manner, and solving the right problem correctly, but in 
the wrong environment, such as post-traumatic stress responses 
(Huys et al., 2015). These models interpret the effect of Selective 
Serotonin Reuptake Inhibitors (SSRIs) as normalizing the learning 
processes, which explains delayed antidepressant response via the 
corollary that further experience is necessary to relearn healthy be-
haviors. Some neuroscientists have sought to localize various psy-
chiatric dysfunctions to the cortico-striato-thalamo-cortical loops, 
which RL connects to deficits in model-based learning or learning 
algorithms that build models of their environment to play more 
adaptively (Huys et al., 2016). Biological models can more pre-
cisely represent these circuits and have predictive power for disease 
progression or treatment effects. 
Deep Learning
Deep learning has a unique connection to neuroscience as it is based 
on a reductive model of biological neural networks--neurons are 
viewed as simple computation devices that gain expressive power 
through their processing in a parallel and distributed manner--and 
can therefore model neural systems. Image recognition networks 
have been shown to replicate the visual cortex functional hierarchy 
(Richards et al., 2019). These have not yet been used to explicitly 
model psychiatric dysfunction, but initial forays should be expect-
ed in the near future. These systems are also effective in data-driven 
algorithms, and it is plausible that they will be used in each manner.
Hybrid Models
Hybrid models seek to utilize theory to develop features for da-
ta-driven models, which can improve predictive power by reducing 
noise in the data. Brodersen et al. (2011) modelled auditory cortex 
functional connectivity to identify aphasics--people who have lost 
the capacity of speech due to brain damage--with 98% accuracy. In 
this system, various generative models are fit to a dataset, followed 
by application of supervised algorithms on the features in the gen-
erative models (Brodersen et al., 2014; Stephan et al., 2015; Wicki 
et al., 2015). With a hybrid model, Frassle et al. (2020) classified 
depressive patients as chronic versus remissive with 79% accuracy, 
although the training set was quite small, at 85 subjects. Similar to 
deep learning models, more of these approaches should be expect-
ed in the near future. Using these models might be the most effec-
tive single way to bring computational psychiatry into the clinic, as 
it leverages the benefits of each type of approach. 
Theoretical models lean more heavily on the research side of com-
putational psychiatry, and therefore they have been treated with 
skepticism as to their potential efficacy in a clinical setting. How-
ever, a properly designed model provides a general framework that 
can be tailored to an individual patient, thus allowing for precision 
medicine, much like a laboratory test provides specific measure-
ments that can be tied to a theoretical model of physiology to gain 
insight into that particular patient’s disorder.
COMPUTATIONAL APPROACHES ON CLINICAL DE-
PRESSION
In this section, I review a selection of studies on Major Depressive 
Disorder. These are not exhaustive but indicative of current trends.
Data-Driven Studies
Patel et al. (2016) summarize early computational psychiatry 
studies that use MRI data and focused on diagnosis. None of the 
patient samples exceeded 80 subjects, and methods tended to be 
linear, usually filtering voxels--individual pixels in an fMRI record-
ing--with an unsupervised algorithm or functional knowledge. The 
following studies utilize more modern approaches. 
Islam et al. (2018) extracted data from 7,145 Facebook comments 
to identify phrases that could predict depression, which they iden-
tified via a supervised model. They identified phrases with emo-
tional, temporal, social, or perceptual qualities that significantly 
predicted onset of MDD. Chekroud et al. (2018) similarly used a 
dataset with 20,785 subjects from U.S national surveys to deter-
mine whether a patient would seek treatment, doing so with 70.6% 
accuracy. It should be noted that this dataset was skewed female 
and white (72% and 77% respectively). Relevant predictors for ini-
tiation of treatment included dropping out of college or having no 
serious suicidal ideation. This model exemplifies how the compu-
tational methods discussed in this paper can not only prove rele-
vant for clinical research, but also for a clinical setting. One would 
simply have to input phrases that a patient used into this system to 
determine whether or not they might be depressive.
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Webb et al. (2018) identified a subset of 216 MDD patients that 
preferentially responded to sertraline (an SSRI) who were older, 
employed, more neurotic and depressive, and having stronger cog-
nitive control than average. Bondar et al. (2020) utilized an unsu-
pervised learning algorithm to identify two symptom clusters in ad-
olescent depressives (n = 439), in which the first (social withdrawal, 
insomnia, fatigue, etc.) responded well to fluoxetine, an SSRI, and 
cognitive behavioral therapy, whereas the other (increased appetite, 
guilt, suicidal ideation, etc.) did not. Chekroud et al. (2016) utilized 
the open-source STAR*D database to identify variables to predict 
remission after citalopram treatment, finding significant contribu-
tion from employment status, psychomotor agitation, race, educa-
tion, and more. Importantly, these are features that a psychiatrist 
might deem relevant. 
Theoretical Studies
Generative models of depression are especially difficult to develop 
due to the heterogeneity of the disorder. Depression is associated 
with deficits in reward learning, especially in effort valuation (Hu-
sain & Roiser, 2018). Kumar et al. (2008) localized diminished pre-
diction error signals in the ventral striatum, which correlated with a 
reduction in responsiveness to antidepressants. However, Rutledge 
et al. (2017) disputed this result in a larger sample, finding that 
moderately depressed patients maintained control-level reward pre-
diction error signals. They utilized a computational model of happi-
ness and found that severe MDD patients fit to this model differed 
only from controls by a static mood intercept, which the authors in-
terpreted as a dysfunction in higher-order processing. These results 
agree with the psychological theory of baselines, which argues that 
a person’s happiness at any given time is related to their baseline 
quality of life (Young et al., 1996).
HOW ARE THEORY-DRIVEN MODELS BETTER SUITED TO 
NEUROPSYCHIATRY?
Theory-driven models emphasize underlying neural pathology. 
Biologically-driven theories attempt to explain features, such as 
the dysfunction of neurotransmitter systems, that can be further 
represented mathematically (Stephan et al., 2015). These mod-
els have strong predictive capabilities and can be further vali-
dated in translational animal studies, which allow for invasive 
experiments (Stephan et al., 2015). Additionally, they allow for 
the simulation of realistic data which could be used to predict 
disease progression (Frassle et al., 2017). Data-driven approach-
es do not have these capabilities, and these “black-box” mod-
els--so-called because their inner workings are not fully under-
stood--can learn discriminatory representations if the data itself 
is biased, a historical problem in medicine. On the other hand, 
the interpretability and strict assumptions of theoretical models 
limit bias (Rutledge et al., 2019; Chandler et al., 2019). 
 Generative models that holistically represent dysfunctions as pa-
rameters or dynamics can be directly connected with individual 
patients, thus “treating the patient not the disease” (Stephan et 
al., 2015). Such approaches can additionally account for fine-
grained changes which ripple to the global scale and to behavior. 
Because psychiatric disorders have been associated with system-
ic neuromodulator dysfunction, this is appealing. For example, 
the dopaminergic system is hypothesized to function as a pre-
diction error signal, which is the learning signal in RL (Schultz 
et al., 1997). Similarly, serotonin has been theorized as a dis-
counting parameter in a utility function, although it certainly has 
multiple functions (Huys et al., 2015). A discounting parameter 
is another feature in an RL algorithm that quantifies how much 
an agent “cares” about the future relative to the present, which is 
measured as an exponentially weighted sum of expected rewards. 
These theories provide explanations for the effects of therapeu-
tics, while data-driven approaches cannot. Even better, genera-
tive models of adaptive plasticity can predict the mechanisms of 
treatment response based on the patient’s “neurotype” (Vinogra-
dov, 2017).
Frassle et al. (2017) note that high dimensionality—the sheer 
number of features per data point—of neuroimaging introduces 
high levels of variance that is challenging even for ML. Howev-
er, biologically interpretable features can separate classes of pa-
tients, on which traditional ML techniques can make predictions. 
An added benefit is that models can be compared to optimally 
explain a set of symptoms (Bennett et al., 2019). 
WHAT ARE SOME ISSUES WITH THEORY-DRIVEN MOD-
ELS?
Precise mechanistic models are needed to sufficiently capture 
neural dynamics, which is a huge challenge. An incorrect or 
non-parsimonious model (one that is not sufficiently simplified 
while remaining precise) is likely to extract results from noise 
and therefore overfit (Deco & Kringelbach, 2014). The tempo-
rospatial restrictions of neuroimaging, as mentioned above, limit 
the ability of generative models to represent underlying activity. 
The complexity of whole brain models makes optimization in-
creasingly intractable (not computable in a reasonable amount 
of time). Ultimately, an increase in computational power, sample 
size, and algorithmic heuristics will be required to train these 
systems to a functional level, just as the deep learning communi-
ty found in the early 2010s (Chen & Lin, 2014). Theory-driven 
approaches have mainly focused on schizophrenia to date, but fu-
ture trends will include other disorders (deFilippis et al., 2019). 
Like data-driven models, these systems have yet to move past the 
exploratory phase (Frassle et al., 2017). 
Despite the fact that these methods are still in their infancy, it is 
likely that just as in other medicines, psychiatrists will soon im-
plement artificial intelligence to aid their decision making. How 
might this look in practice? In the following section, I provide 
a novel four-step proposal that seeks to use the computational 
tools, developed by contemporary and future research, in a maxi-
mally-effective manner to treat mental health disorders. 
A NOVEL PROPOSAL FOR THE CLINICAL IMPLEMENTA-
TION OF COMPUTATIONAL SYSTEMS
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In this section, I envision an integration of theory and data-driv-
en models in clinical practice. The proposal contains four basic 
steps with a recurrence paradigm for long-term treatment when 
computational psychiatry approaches are sufficient for medicinal 
use. The following steps require a comprehensive set of algo-
rithms to utilize all informative data. Note that this is a gener-
al plan and would require further personalization for precision 
medicine.
1. Immediate Treatment
Many psychiatric disorders require immediate treatment, such as 
suicidal ideation. Data-driven algorithms using information that is 
immediately collectable can provide initial treatment recommen-
dations.
2. Biological data and theoretical models
Many psychiatric disorders require immediate treatment, such as 
suicidal ideation. Data-driven algorithms using information that is 
immediately collectable can provide initial treatment recommen-
dations.
3. Longitudinal data collection
Over a specified time, the patient utilizes a smartphone applica-
tion to record relevant data, such as sleep and movement, along-
side surveys or virtual therapy sessions. These are factored into 
the history portion of the model in order to capture the dynamics 
of the patient’s disorder.
4. Informed, holistic treatment
As treatment continues, the historical information is integrated 
into a single, cumulative model, and a clinician designs a more 
general treatment plan. Efficacy of the treatment can be revised 
by repeating these steps. This precision medicine approach ac-
counts for many of the elements of experience desired by vo-
cal opponents to personalized psychiatry (Stiefel at al., 2019). 
No single step will be sufficient, as indicated by preliminary re-
search. 
DISCUSSION
The development of computational psychiatry is still explorato-
ry; clinical efficacy is far off. ML is a necessary tool but not 
a silver bullet; applying these models unintelligently will not 
suddenly solve decades-old problems. Simon (2019) makes an 
excellent analogy, emphasizing that despite the hype of ML, we 
cannot become like a child with a hammer, pounding anything 
that looks like a nail. Contrarians argue that computational mod-
els cannot be as effective as a clinician, because they do not have 
an understanding of subjective experience. 
Translational computational tools need to derive from basic 
science. Neuroscience and psychiatry will benefit greatly from 
scientists who have rigorously studied theory and methodology 
(Mai-an Vu et al., 2018; Cearns et al., 2019). Theoretical ap-
proaches have yet to begin answering the questions desired of 
computational psychiatry due to extensive methodological devel-
opment. Asking the right questions is crucial, and we must take 
the time to do so. Are our computational tools powerful enough 
for these approaches? The answer is yes, but the more pertinent 
question is whether we have the right type of data. Computation-
al psychiatry researchers are hence cautiously optimistic about 
the clinical viability of ML methods (Chekroud & Koutsouleris, 
2017). 
CONCLUSION
Perhaps it is too early to determine whether theoretical or da-
ta-driven approaches will be more efficacious for the future of 
computational psychiatry and clinical practice. In all likelihood, 
both methods will be necessary. The majority of research in this 
field requires a stronger theoretical foundation that will currently 
hinder the development of clinical tools, but it is still import-
ant to consider how clinical research can translate. This will be 
useful to psychiatry in general, as biologically-backed theories 
can help improve the definitions and treatments of disorders in 
the DSM. Psychiatritfsts will of course never be phased out, but 
machine learning algorithms can pick up trends that even the ex-
pert eye cannot capture in vast amounts of data. Furthermore, 
efforts to create testable theoretical models must keep pace with 
their counterpart as these studies will be more informative in the 
long run. Scientists, hospitals, and therapy developers will need 
to communicate intensively to steer psychiatry into a new era. 
With time, psychiatry will soon join other disciplines in the era 
of precision medicine.
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In the Seo Lab at the Yale School of Medicine, senior Mitchell Ostrow 
found his passion at the intersection of computational modeling, machine 
learning, and neuroscience—studying deep neural networks as models of the 
brain. To Ostrow, studying these models is especially exciting because through 
artificial intelligence, his findings can directly impact the world on top of moving science forward. 
For example, they could potentially be used to synthesize drugs or devise new treatments imme-
diately. Ultimately, Ostrow’s commitment to pursuing what intrigued him the most led him to this 
research area. 
“From doing so much exploration, I was able to really narrow down my interests and find some-
thing that I absolutely love and can definitely see myself doing for the rest of my life,” Ostrow said. 
Right now, that means pursuing a PhD in Computational Neuroscience to study the intersection of 
AI and neuroscience.
Outside of research, Ostrow enjoys exercise and spending time in nature. Additionally, he is heav-
ily invested in music, formerly playing trombone in the Yale Symphony Orchestra, a trombone 
choir called Scale and Bones (which he founded), and a brass choir called Coup de Brass. Before 
college, his identity was predominantly as a trombone player and as a musician. Although he still 
sees himself in this way, his identity has transformed into that of a researcher.
Surprisingly, he has found commonalities among these two worlds. Initially, most of your time is 
spent developing technical skills—such as playing scales for trombone and learning how to analyze 
papers in research. As you progress, however, you develop your own style or you create your own 
experiments, and creativity flourishes. Moreover, music and research are both personally reward-
ing as well as community-oriented.
“Science is for society to gain knowledge and music is for other people to enjoy,” Ostrow said. “To 
me, it’s more about appreciating the music or appreciating creating knowledge for myself, and it’s 
an added benefit that other people enjoy it.”
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